Document is current

Any future updates will be listed below

Sevabertinib in den USA bei NSCLC zugelassen

Crossref DOI link: https://doi.org/10.1007/s15004-025-1240-2

Published Online: 2026-02-03

Published Print: 2026-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark